US Broker Ratings

AdaptHealth Corp. (AHCO) Stock Analysis: A 24% Upside Amidst Healthcare Sector Shifts

AdaptHealth Corp. (NASDAQ: AHCO) is a company that has captured the attention of investors with its solid footing in the healthcare sector, specifically within the medical devices industry. As a..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Potential 31.84% Upside Despite Revenue Challenges

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, stands out with a market capitalization of $5.5 billion. Headquartered in Warren, New Jersey, the company focuses on..

Agios Pharmaceuticals (AGIO) Stock Analysis: Biotech Growth Potential with a 41.85% Upside

Agios Pharmaceuticals, Inc. (AGIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising growth potential. Headquartered in Cambridge, Massachusetts, Agios focuses on discovering..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals 39% Upside Potential Driven by Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a burgeoning player in the biotechnology space, is capturing the attention of investors with a compelling growth narrative. With a market capitalization of $5.4 billion,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A 49.66% Potential Upside Beckons Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling opportunity for investors, particularly those focused on the healthcare sector. Operating within the niche of Drug Manufacturers – Specialty & Generic, ANI..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Steady Growth and Strategic Collaborations Fuel Investor Interest

Investors eyeing the healthcare sector may find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing prospect. As a commercial-stage biopharmaceutical company with a focus on vaccine development, Dynavax has positioned itself..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Player in the Medical Care Facilities Sector

National HealthCare Corporation (NYSE: NHC) is a notable entity within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2.51 billion, NHC operates a..

CONMED Corporation (CNMD) Stock Analysis: Unpacking a 20.67% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (NASDAQ: CNMD) an intriguing prospect, especially given its potential upside of 20.67% according to recent analyst ratings. As a..

GRAIL, Inc. (GRAL) Stock Analysis: A Promising Upside in the Diagnostics & Research Sector

For investors seeking exposure in the healthcare sector, GRAIL, Inc. (NASDAQ: GRAL) presents an intriguing opportunity. With a market capitalization of $2.02 billion, GRAIL operates in the diagnostics and research..

Immunocore Holdings plc (IMCR) Stock Analysis: Unpacking the 110% Potential Upside in Biotech Advancements

Immunocore Holdings plc (NASDAQ: IMCR) is making waves in the biotechnology sector, capturing the attention of investors with its innovative approach to immunomodulating medicines and a striking potential upside of..

Disc Medicine, Inc. (IRON) Stock Analysis: A Biotech Gem with 69% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON) is capturing significant attention within the biotechnology sector, not only for its innovative approach to addressing serious hematologic diseases but also for its compelling investment..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Exploring a 39% Potential Upside Amidst Healthcare Sector Challenges

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers a compelling investment opportunity with a potential upside of..

Travere Therapeutics, Inc. (TVTX): Investor Outlook Reveals 53.93% Upside Potential

Travere Therapeutics, Inc. (NASDAQ: TVTX) is making waves in the biopharmaceutical sector with its innovative approach to treating rare kidney and metabolic diseases. With a market capitalization of $2.56 billion,..

Phreesia, Inc. (PHR) Stock Analysis: Unveiling a 137.73% Potential Upside in Healthcare SaaS

Phreesia, Inc. (NYSE: PHR), a prominent player in the health information services industry, is capturing investor attention with a remarkable potential upside of 137.73%. This intriguing figure stems from the..

Clover Health Investments (CLOV): Investor Outlook Amid 52.25% Potential Upside

Clover Health Investments, Corp. (CLOV), a prominent player in the healthcare plans sector, is attracting considerable attention from investors, especially with a potential upside of 52.25% based on current analyst..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Omnicell, Inc. (OMCL) Stock Analysis: 67% Potential Upside with Strong Buy Ratings

Omnicell, Inc. (OMCL), a leader in healthcare technology innovation, is capturing investor attention with its promising growth trajectory and substantial potential upside. With a market capitalization of $1.56 billion, Omnicell..

Apellis Pharmaceuticals, Inc. (APLS): Investor Outlook with a 90% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a compelling player in the biotechnology sector, offering investors a unique opportunity to engage in innovative healthcare solutions. With a market capitalization of $2.25..

Addus HomeCare Corporation (ADUS) Stock Analysis: Potential 40% Upside Amid Robust Growth

Investors looking for opportunities in the healthcare sector might want to turn their attention to Addus HomeCare Corporation (NASDAQ: ADUS), a noteworthy player in the medical care facilities industry. With..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Impressive Potential with a 59% Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has been making waves in the healthcare sector, specifically within the realm of drug manufacturing for specialty and generic markets. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds